tradingkey.logo
搜索

Eloxx Pharmaceuticals Ord Shs

ELOX
添加自选
13.150USD
+0.260+2.02%
收盘 11-13 16:00(美东)
53.13M总市值
0.00市盈率 TTM

Eloxx Pharmaceuticals Ord Shs

13.150
+0.260+2.02%

关于 Eloxx Pharmaceuticals Ord Shs 公司

Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the science of ribosome modulation, leveraging both its TURBO- ZM chemistry technology platform and its library of aminoglycosides to develop oral small-molecule ribosome modulating agents (RMAs) and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare genetic diseases. Its lead investigational product candidate, ELX-02, is a small molecule drug candidate designed to restore production of full-length functional proteins. The Company is also advancing ZKN-013 as an oral agent for the treatment of recessive dystrophic (RDEB)/ junctional epidermolysis bullosa (JEB) and familial adenomatous polyposis (FAP) patients with nonsense mutations. The Company also has preclinical programs focused on select rare diseases, including inherited diseases, cancer caused by nonsense mutations, kidney diseases, as well as rare ocular genetic disorders.

Eloxx Pharmaceuticals Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

Eloxx Pharmaceuticals Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Mr. Stephen W. Webster
Mr. Stephen W. Webster
Independent Director
Independent Director
--
--
Mr. Steven Rubin, J.D.
Mr. Steven Rubin, J.D.
Independent Director
Independent Director
--
--
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Mr. Sumit Aggarwal
Mr. Sumit Aggarwal
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.07K
-0.00%
Ms. Nina Kjellson
Ms. Nina Kjellson
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--
Mr. Geno J. Germano
Mr. Geno J. Germano
Independent Director
Independent Director
--
--

常见问题

Eloxx Pharmaceuticals Ord Shs的前五大股东是谁?

Eloxx Pharmaceuticals Ord Shs 的前五大股东如下:Mr. Sumit Aggarwal
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有